Synchroneuron raises $6M Series A; Rib-X scores $3M milestone; smoking makes you stupid;

@FierceBiotech: GSK will cut 3 research units, add 4 as R&D productivity swells. Witty pronounced himself satisfied. Article | Follow @FierceBiotech

@JohnCFierce: GSK completes tally on DPUs: 3 gone, 4 added, 8 get new chiefs. Productivity up. Seem pretty happy with the direction. News | Follow @JohnCFierce

@FierceMedDev: Consumers Union pushes to improve medical device safety: Story | Follow @FierceMedDev

> Waltham, MA-based Synchroneuron has rounded up $6 million in a Series A designed to support its work on a new treatment for Tardive dyskinesia. Story

> Rib-X Pharmaceuticals says it snagged a $3 million milestone from Sanofi. Release

> Five Prime Therapeutics says it will officially make Lewis Williams its CEO. News

Pharma News

@FiercePharma: Big Pharma needs to enroll at Hogwarts, the FT says. Article | Follow @FiercePharma

> Daiichi shops India for bolt-on deals, ET says. More

> What can Big Pharma learn from an NYT bestseller? Item

> Reuters: Nestle leads pack of bidders for Pfizer nutrition unit. Story

> Bayer CEO: Shortsighted price cuts lead to long-term pain. Article

> How do the 12 priciest drugs in the U.S. stack up? Piece

Research News

> CA stem cell researchers planning for life without state funding. Item

> In a breakthrough, scientists blame tau proteins for spreading Alzheimer's. More

> Silver, slayer of werewolves, explored as cancer fighter. Article

> Walnuts slow prostate cancer tumor growth in mice. Story

> Can't get enough donuts? A specific gene variation may explain why. More

Manufacturing News

> FDA report shows deep problems at closed Novartis Consumer Health plant. More

> Merck's manufacturing information not trade secrets, court rules. News

> AstraZeneca faces resistance to job cuts on home turf. Story

> Dishman set to bail on API manufacturing in once-promising China. Article

> Smith & Nephew eliminating 800 jobs, restructuring already felt in Memphis. News

And Finally... Smoking isn't just stupid in and of itself. It also makes you dumber over time, according to a new study. Report

Suggested Articles

The phase 1 and 2 results suggest the vaccine may be safe, tolerable and capable of triggering production of antibodies against the coronavirus.

The platform, which is in use at companies including Agios, enables researchers to simultaneously detect DNA and protein changes in single cells. 

As Urovant gears up for the launch of vibegron, its overactive bladder treatment, it is pushing the same drug through the clinic in other indications.